RE: Wow ....19 Feb 2026 09:10
@takecare - from the 31/05/24 RNS:
“To further incentivise and reward the Valereum workforce for delivering growth in market capitalisation, a market capitalisation performance incentive has been approved whereby options amounting to 5% of the outstanding shares in issue will be awarded if the Company achieves each of the market capitalisations as follows:
● £50,000,000 Market Capitalisation
● £100,000,000 Market Capitalisation
● £150,000,000 Market Capitalisation
● £200,000,000 Market Capitalisation
In each case for a consecutive period of 10 days. The options will be allocated on a discretionary basis based on Remuneration Committee recommendations to the Board and the exercise price of the options will be based on the average closing share price in the 3 months before the date of award and will vest over 4 equal six monthly tranches over 2 years.
The remuneration as outlined above will be subject to annual reviews commencing 1st January 2025 in consideration of the Company's performance in the preceding calendar year.”
I don’t think we heard anything about a review, so it’s probably best to assume the above still applies.